Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why BioCryst Pharmaceuticals Stock Is Soaring Today

TheMotleyFool

0 0

Why BioCryst Pharmaceuticals Stock Is Soaring Today: https://g.foolcdn.com/editorial/images/730749/pig-taking-flight.jpg

Shares of BioCryst Pharmaceuticals (NASDAQ: BCRX) were up by a healthy 14% as of 1:40 p.m. ET Wednesday. The big gain came after the small-cap biotech reported first-quarter earnings ahead of the opening bell.

Although it missed Wall Street's consensus top-line estimate by $2.6 million for the quarter, investors appear to be more concerned about BioCryst's overall financial health and near-term outlook.

BioCryst said that in Q1, the number of U.S. patients taking its oral hereditary angioedema (HAE) drug Orladeyo rose by 46% year over year. Meanwhile, its research and development expenses plunged by 26% due to the discontinuation of its BCX9930 and BCX9250 programs.

Source Fool.com

Like: 0

BCRX

Share